TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
STTK

Shattuck Labs Inc

Healthcare · Biotechnology

6.50$ +1.7% vs. previous close Closing price · As of: Sep 29, 2026

Ownership

Ownership Structure

Who owns Shattuck Labs Inc (STTK)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.5% of the shares are freely tradable; institutional investors hold 67.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 67.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 67.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 100Mio.

Largest Shareholders

Institutions

Institutions STTK
Name Stake (%) Shares Change (%) Date
T. Rowe Price Investment Management,Inc. 9.83 9,865,558 +430.1 03/31/2026
Adage Capital Partners Gp LLC 8.09 8,122,179 +74.9 06/30/2026
Redmile Group, LLC 6.87 6,892,033 +24.4 06/30/2026
Orbimed Advisors LLC 6.28 6,306,127 +0.0 03/31/2026
Prosight Management, LP 5.94 5,957,877 +19.1 06/30/2026
NEXTBio Capital Management LP 3.71 3,727,348 +18.3 06/30/2026
Deep Track Capital, LP 3.69 3,706,734 +0.0 06/30/2026

Funds

Funds STTK
Name Stake (%) Shares Change (%) Date
T. Rowe Price Small-Cap Value 3.48 3,493,664 -2.0 07/31/2026
T. Rowe Price Small-Cap Stock 3.10 3,112,183 -0.1 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.36 2,366,616 +0.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?